VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $1.55M invested in Pacer BioThreat Strategy ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$129K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.96K |
Top Sellers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10.6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $658K | +$129K | +4,312 | +24% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $527K | +$22.3K | +747 | +4% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $362K | -$10.6K | -355 | -3% |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.96K | +$5.96K | +200 | New |
|